MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases-Reference-Cited by-同舟云学术

MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases

Published:2022-05-25 Issue:7 Volume:39 Page:3403-3422
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Hellstrom Wayne J. G.^ORCID,Dolhain Radboud J. E. M.,Ritter Timothy E.,Watkins Timothy R.,Arterburn Sarah J.,Dekkers Goele,Gillen Angi,Tonussi Caroline,Gilles Leen,Oortwijn Alessandra,Van Beneden Katrien,de Vries Dick E.,Sikka Suresh C.,Vanderschueren Dirk,Reinisch Walter

Funder

Galapagos NV

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-022-02168-4.pdf

Reference47 articles.

1. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.

2. Safiri S, Kolahi AA, Hoy D, et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis. 2019;78(11):1463–71.